Superbug crisis - time to pay drug firms?

ReutersNewsPublished: May 19, 20162 views
Published: May 19, 2016

UK government-commissioned review proposes to charge drug companies a levy to help fund development of new antibiotics to tackle the global threat of antimicrobial resistance. Laura Frykberg reports.

Be the first to suggest a tag

    Comments

    0 comments